======= STXBP3 ======= == Gene Information == * **Official Symbol**: STXBP3 * **Official Name**: syntaxin binding protein 3 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=6814|6814]] * **UniProt**: [[https://www.uniprot.org/uniprot/O00186|O00186]] * **Interactions**: [[https://thebiogrid.org/search.php?search=STXBP3&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20STXBP3|Open PubMed]] * **OMIM**: [[https://omim.org/entry/608339|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Together with STX4 and VAMP2, may play a role in insulin-dependent movement of GLUT4 and in docking/fusion of intracellular GLUT4-containing vesicles with the cell surface in adipocytes. {ECO:0000250}. |Sec1| |protein to membrane docking| |tertiary granule| |negative regulation of calcium ion-dependent exocytosis| |negative regulation of glucose import| |specific granule| |platelet alpha granule| |negative regulation of glucose transmembrane transport| |negative regulation of regulated secretory pathway| |syntaxin-1 binding| |negative regulation of exocytosis| |insulin secretion| |vesicle docking involved in exocytosis| |regulation of calcium ion-dependent exocytosis| |platelet aggregation| |regulation of glucose import| |syntaxin binding| |peptide hormone secretion| |homotypic cell-cell adhesion| |phagocytic vesicle| |vesicle docking| |exocytic process| |hormone secretion| |regulation of glucose transmembrane transport| |hormone transport| |cellular glucose homeostasis| |presynapse| |protein heterooligomerization| |negative regulation of transmembrane transport| |platelet activation| |protein secretion| |establishment of protein localization to extracellular region| |cellular response to interferon-gamma| |regulation of regulated secretory pathway| |protein localization to extracellular region| |signal release| |organelle localization by membrane tethering| |peptide secretion| |membrane docking| |response to interferon-gamma| |glucose homeostasis| |carbohydrate homeostasis| |basolateral plasma membrane| |negative regulation of secretion by cell| |regulation of exocytosis| |response to insulin| |negative regulation of secretion| |blood coagulation| |coagulation| |hemostasis| |apical plasma membrane| |response to peptide hormone| |response to peptide| |wound healing| |negative regulation of transport| |neutrophil degranulation| |neutrophil activation involved in immune response| |regulation of body fluid levels| |neutrophil mediated immunity| |neutrophil activation| |cell-cell adhesion| |granulocyte activation| |leukocyte degranulation| |myeloid leukocyte mediated immunity| |protein complex oligomerization| |myeloid cell activation involved in immune response| |regulation of hormone levels| |regulation of vesicle-mediated transport| |regulation of transmembrane transport| |response to wounding| |organelle localization| |myeloid leukocyte activation| |leukocyte activation involved in immune response| |cell activation involved in immune response| |regulated exocytosis| |brain development| |cellular chemical homeostasis| |regulation of secretion by cell| |innate immune response| |leukocyte mediated immunity| |head development| |exocytosis| |regulation of secretion| |cellular homeostasis| |response to hormone| |leukocyte activation| |cell adhesion| |biological adhesion| |defense response to other organism| |central nervous system development| |response to organonitrogen compound| |secretion by cell| |cellular response to cytokine stimulus| |export from cell| |cell activation| |response to nitrogen compound| |immune effector process| |response to cytokine| |chemical homeostasis| |cell-cell signaling| |secretion| |response to other organism| |response to external biotic stimulus| |response to biotic stimulus| |defense response| |response to endogenous stimulus| |protein transport| |peptide transport| |response to oxygen-containing compound| |protein-containing complex assembly| |amide transport| |establishment of protein localization| |homeostatic process| |nitrogen compound transport| |protein-containing complex subunit organization| |regulation of transport| |immune response| |vesicle-mediated transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp111|R-DABN 8μM R03 exp111]]|1.74| |[[:results:exp240|Pyridostatin 4μM R05 exp240]]|1.78| |[[:results:exp415|Trichostatin-A 0.06μM R07 exp415]]|1.8| |[[:results:exp68|Clomiphene 4.4μM R02 exp68]]|2.72| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 12/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|3/28| |blood|1/28| |bone|0/26| |breast|2/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|3/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 6839 * **Expression level (log2 read counts)**: 5.55 {{:chemogenomics:nalm6 dist.png?nolink |}}